Publicaciones en las que colabora con JOSÉ LUIS BALIBREA CANTERO (63)

2013

  1. The differential tissue expression of inflammatory, oxidative stress, and apoptosis markers in human uncontrolled non-heart-beating donors

    Transplantation, Vol. 95, Núm. 11, pp. 1346-1353

2011

  1. Tacrolimus modulates liver and pancreas nitric oxide synthetase and heme-oxygenase isoforms and cytokine production after endotoxemia

    Nitric Oxide - Biology and Chemistry, Vol. 24, Núm. 2, pp. 113-122

2010

  1. Cytoprotective effect of low-dose tacrolimus on islets of Langerhans in cultures subjected to stimulation by acute rejection cytokines

    Cirugia Espanola, Vol. 87, Núm. 6, pp. 372-377

2007

  1. Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer

    Oncology Reports, Vol. 17, Núm. 1, pp. 217-223

  2. Current status of islet transplantation

    Cirugia Espanola, Vol. 81, Núm. 4, pp. 177-191

  3. Expression of MMP-9 and TIMP-1 as prognostic markers in gastric carcinoma

    Hepato-Gastroenterology, Vol. 54, Núm. 73, pp. 315-319

2006

  1. Correlations of telomere length, telomerase activity, and telomerlc-repeat binding factor 1 expression in colorectal carcinoma: Prognostic indications

    Cancer, Vol. 106, Núm. 3, pp. 541-551

  2. Efficacy of albendazole against Anisakis simplex larvae in vitro

    Digestive and Liver Disease, Vol. 38, Núm. 1, pp. 24-26

2005

  1. Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer

    Oncology Reports, Vol. 13, Núm. 1, pp. 115-120

  2. Glucose intolerance modifies the inflammatory response after intestinal ischemia-reperfusion

    World Journal of Surgery, Vol. 29, Núm. 9, pp. 1143-1150

  3. Portal hypertension produces an evolutive hepato-intestinal pro- and anti-inflammatory response in the rat

    Cytokine, Vol. 31, Núm. 3, pp. 213-226

2004

  1. Differential impact of p16 inactivation by promoter methylation in non-small cell lung and colorectal cancer: clinical implications.

    International journal of oncology, Vol. 24, Núm. 2, pp. 349-355

  2. Relationship between 3p deletions and telomerase activity in non-small-cell lung cancer: Prognostic implications

    British Journal of Cancer, Vol. 90, Núm. 10, pp. 1983-1988

2003

  1. Surfactant strengthens the inhibitory effect of C-reactive protein on human lung macrophage cytokine release

    American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 284, Núm. 3 28-3

2002

  1. Cooperative role of telomerase activity and p16 expression in the prognosis of non-small-cell lung cancer

    Journal of Clinical Oncology, Vol. 20, Núm. 1, pp. 254-262

  2. Genomic organization of a novel glycosylphosphatidylinositol MAM gene expressed in human tissues and tumors

    Oncogene, Vol. 21, Núm. 19, pp. 3089-3094

  3. Modificación de los mediadores inflamatorios en isquemia-reperfusión intestinal en un modelo de diabetes tipo 2

    Cirugia Espanola, Vol. 71, Núm. 6, pp. 276-286

  4. Stromelysin-1 promoter mutations impair gelatinase B activation in high microsatellite instability sporadic colorectal tumors

    Cancer Research, Vol. 62, Núm. 13, pp. 3855-3860

2001

  1. Glucagon-like peptide-1(7-36) amide stimulates surfactant secretion in human type II pneumocytes

    American Journal of Respiratory and Critical Care Medicine, Vol. 163, Núm. 4, pp. 840-846

  2. Update in clinical islet transplantation

    Cirugia Espanola, Vol. 70, Núm. 6, pp. 310-313